Frontlight ResearchEarly access
Trial site
Hospital Universitario San Juan de Alicante
- 11running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer7 trials
- Asthma3 trials
- Triple-negative breast cancer2 trials
- Ankylosing spondylitis1 trial
- Brain metastases1 trial
- Familial hypercholesterolaemia1 trial
- Haemophilia1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Rheumatoid arthritis1 trial
- and 2 more
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 44 trials
- Phase 1/22 trials
- Status
- Recruiting7 trials
- Completed5 trials
- Not yet recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- MedSIR4 trials
- Inmunotek S.L.2 trials
- Cantargia AB1 trial
- Emory University1 trial
- Fundacion Grupo Espanol De Investigacion En Cancer De Mama1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma3 recruiting
- Metastatic breast cancer2 recruiting
- Ankylosing spondylitis1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Haemophilia1 recruiting
- Lung cancer1 recruiting
- Lupus (SLE)1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
Site data: ClinicalTrials.govUpdated 17 Nov 2026